Trevena Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
37,965.20
106,904.20
172,638.00
110,601.00
66,100.00
61,482
Other Current Assets
1,957.80
669.20
1,892.20
1,788.00
1,393.00
607
Total Current Assets
39,923.00
107,573.40
174,530.20
112,389.00
67,493.00
62,089
Net Property, Plant & Equipment
343.10
553.30
696.30
1,059.00
3,805.00
3,387
Total Investments and Advances
112.00
112.40
112.60
1,193.00
1,413.00
1,303
Intangible Assets
-
-
14.80
13.00
11.00
-
Other Assets
2,014.90
98.40
-
-
-
-
Total Assets
42,392.90
108,337.50
175,354.00
114,654.00
72,722.00
66,779
ST Debt & Current Portion LT Debt
-
-
-
5,039.00
12,425.00
Accounts Payable
545.10
4,342.50
6,749.60
8,749.00
1,424.00
Other Current Liabilities
2,191.90
2,616.60
6,823.70
8,260.00
4,364.00
Total Current Liabilities
2,737.00
6,959.10
13,573.30
22,048.00
18,213.00
Long-Term Debt
-
1,802.00
18,193.80
13,288.00
15,756.00
Other Liabilities
664.40
372.80
455.40
737.00
4,120.00
Total Liabilities
3,401.40
9,133.80
32,222.50
36,073.00
38,089.00
Common Equity (Total)
81,570.60
99,203.60
143,131.50
78,581.00
34,633.00
Total Shareholders' Equity
38,991.50
99,203.60
143,131.50
78,581.00
34,633.00
Total Equity
38,991.50
99,203.60
143,131.50
78,581.00
34,633.00
Liabilities & Shareholders' Equity
42,392.90
108,337.50
175,354.00
114,654.00
72,722.00
Preferred Stock (Carrying Value)
120,562.10
-
-
-
-

About Trevena

View Profile
Address
955 Chesterbrook Boulevard
Chesterbrook Pennsylvania 19087
United States
Employees -
Website http://www.trevenainc.com
Updated 07/08/2019
Trevena, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of healthcare services and development of therapies. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A.